The global contract manufacturing market is a crucial part of the pharmaceutical industry, allowing companies to streamline operations, cut costs, and access specialised skills. With the market projected to be worth $319.6 billion by 2029, contract manufacturing is set to remain a key driver of efficiency in healthcare.
However, as the market expands, selecting the right CMO partner has never been more complex. Pharmaceutical companies must ensure product quality, regulatory compliance, and long-term strategic alignment amid global uncertainties, supply chain disruptions, and digital transformation. Issues including pricing pressures, tough contract talks, limited capacity, and strict delivery deadlines add further strain.
The 2026 Pharma Contract Manufacturing Conference will tackle these challenges and provide strategies for building agile and lasting partnerships that go beyond a contract. The forum offers a trusted environment to explore Europe’s most pressing manufacturing issues, share best practices, and engage in targeted networking and supplier matchmaking.
24
speakers
100
industry experts
3
focused days
20
hours networking
Carefully designed to provide our valued CMO/CDMO partners with enhanced visibility, meaningful networking opportunities, and full engagement throughout the conference. This package ensures your team is well-positioned to connect with key industry stakeholders and maximise the value of your participation. Investment: 5,500 euro + 19% VAT
Package Benefits Include:
To secure a seat, book online now. Or, for any assistance, please contact us below.